Holistic care in oncology must be integrated to succeed. As Dr. Dino Prato, Founder of Envita Medical Centers, explains, we focus on treating the underlying cause of illness, supporting the immune system, and targeting the cancer itself. By analyzing hundreds of biomarkers, we tailor treatment plans that align with each patient’s unique genetic makeup and tumor biology. This personalized approach is how we give patients the best chance to overcome cancer, even when traditional treatments have failed. Learn more about Envita’s holistic and personalized cancer care here: envita.com/about #CancerCare #PersonalizedMedicine #HolisticOncology
Envita Medical Centers - Cancer and Lyme Disease Facility’s Post
More Relevant Posts
-
💫 Liquid biopsy is an intriguing development in genomic technology. The field struggles with sensitivity and specificity in establishing its diagnostic and therapeutic effectiveness across different cancer types. One of the primary hurdles is the lack of interpretive algorithms needed to extract life-saving insights from ctDNA detected variants. GenomeArc's Spectra have developed interesting algorithms, offering potential improvements in predictive diagnosis, pharmacogenomics, and cellular progression analysis. Excited to witness future breakthroughs and the growing impact of liquid biopsy in the fight against cancer, potentially even before it manifests. 💫 GenomeArc Horizon Spectra: https://lnkd.in/dzq25Q74 #liquidbiopsy #cancer #genomics
To view or add a comment, sign in
-
The efforts against lung cancer and hepatocellular carcinoma (HCC) are advancing rapidly with the implementation of precision medicine and genomics. * For lung cancer, genomics enables us to move beyond a general approach, offering personalized therapies that improve outcomes. * In HCC, surveillance and screening can be life-saving measures leading to early detection which can significantly reduce the disease burden Stay tuned for more updates on this topic currently being discussed at #RochePHC2024. If you would like our team to reach out to you with further details please click here https://lnkd.in/dGRnCZZg
Stay tuned for more updates on this topic currently being discussed at #RochePHC2024.
To view or add a comment, sign in
-
The age of cancer biomarkers and precision medicine begins with the discovery that HER2 is overexpressed in 20-25% of breast cancers and is associated with adverse outcomes. Herceptin, the first Ab therapeutic for the treatment of solid tumors that blocks the HER2 receptor, is approved in 1998, and ushers in the rise of targeted cancer treatments. What new biomarkers will you discover with spatial biology? Join our panel discussion tomorrow sponsored by Illumina and Life Science Washington to learn how our speakers are using spatial multiomics to advance research on women’s health. 👉https://bit.ly/3VhFfCP #cancertreatment #precisionmedicine #spatialbiology #biomarkerdiscovery #womenshealthwednesdays
To view or add a comment, sign in
-
Take the next step in developing cancer treatment with liquid biopsy technology! Revolutionize cancer care with early detection in the blood, guiding treatment selection, and monitoring response. Our white paper reveals the transformative potential of liquid biopsies and initiatives to establish a vast longitudinal cell-free plasma biobank, providing comprehensive datasets for investigating tumor evolution, heterogeneity, predictive biomarkers, and treatment response. Download now ➡️ https://hubs.la/Q02Blnp70 #LiquidBiopsy #CancerResearch #PrecisionOncology
To view or add a comment, sign in
-
📣 ESMO members: have you already downloaded our latest book Breast Cancer: Essentials for Clinicians (2nd edition)? 👩⚕️ Edited by Fatima Cardoso, Vivianne Tjan-Heijnen, Ivana Božović-Spasojević and Marta Vaz Batista, it combines fundamental with advanced knowledge. 👉 Dive into some of the more nuanced aspects of #BreastCancer care, addressing genetic testing and prognostic and predictive factors, including targeted therapies tailored to breast cancer subtypes and/or specific biomarkers. #ESMObooks 🔗https://ow.ly/IgNF50UjHC4
To view or add a comment, sign in
-
The PRESERVE trial explores tailored treatment strategies for advanced laryngeal/hypopharyngeal cancer, combining clinical, radiomics and genomic data to improve organ preservation. By addressing key challenges in patient selection and treatment response prediction, this study paves the way for personalized cancer care. Editorial support by Polistudium. #PrecisionMedicine #OncologyResearch #PRESERVETrial #MedicalWriting https://lnkd.in/eqk6BGCF
To view or add a comment, sign in
-
How do liquid biopsies work? How are liquid biopsies helping to guide treatment decisions for patients with cancer? Speak to your doctor today about comprehensive genomic profiling tests that can help guide treatment decisions for you. Visit us at https://lnkd.in/gHNdYtQN to find out more about Guardant Health’s comprehensive genomic profiling tests which can help guide treatment decisions for patients with cancer. #guardanthealthamea #guardanthealth #comprehensivegenomicprofiling #precisiononcology #liquidbiopsy #liquidissolid #cancerpatients
How do liquid biopsies help guide treatment decisions for patients with cancer?
To view or add a comment, sign in
-
𝗤𝘂𝗶𝗰𝗸 𝗳𝗮𝗰𝘁 𝘀𝗲𝗿𝗶𝗲𝘀: 𝗦𝗲𝗿𝗶𝗲𝘀 𝟴: 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗙𝗮𝗰𝘁 𝟰: What the fuss around molecular testing/ targeted therapy in cancer treatment? Molecular testing is done with two goals: 1. To establish the primary site of origin and select the best suited systemic therapy which could result in a better response compared to empirical therapy 2. To identify the druggable mutations (ref table below) Remember: - Both NCCN and ESMO guidelines recommend molecular testing in patients with CUP. - In CUP, molecular tests have an accuracy of over 80% for correctly identifying the primary site. #oncology #oncopathology #FRCPath #histopathology #unknownprimary #cancer #TargetRoyalFellow
To view or add a comment, sign in
-
Our Chief Scientific Officer, Dr Hongtao Lu, will be speaking at the 6th Cell Engager Summit in Boston! Join us on Conference Day 2, May 22nd at 3:00 pm, for Hongtao Lu's presentation on "Exploiting Phagocytosis with Macrophage Engagers to Enhance Tumor Killing in Solid Tumors." The talk will cover: l Advantages of using macrophage phagocytosis for cancer treatment l Challenges in developing macrophage engagers l Using innate immune cells to better target solid tumors Make sure to attend this insightful session! https://lnkd.in/gJaQV6vR #CellEngagerSummit #CancerResearch #MacrophageEngagers #Elpiscience #InnovationInOncology.
To view or add a comment, sign in
-
Traditional cancer treatments don't work for everyone. Sometimes a personalised approach is needed. In this video, Dr Nine explains how precision cancer treatment uses detailed genomic profiles to tailor treatments specifically for you, improving effectiveness and reducing side effects. By analysing your tumour's genetic makeup, we identify specific mutations and choose the most effective treatments, targeting cancer cells while sparing healthy tissue. At HealthDeliver, our goal is to offer the most advanced and personalised cancer care. If you have questions or want to learn more, schedule a consultation with Dr Nine at https://lnkd.in/dNJH-Y8t #HealthDeliver #CancerTreatment #PrecisionMedicine #Oncology #Wellness
To view or add a comment, sign in
4,147 followers